ArticleIranian journal of basic medical sciences2013
Expression of recombinant streptokinase from streptococcus pyogenes and its reaction with infected human and murine sera.
Article in Iranian journal of basic medical sciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 19 citations in OpenAlex.
- Recombinant Production of Ib-AMPProtein and peptide letters · 2025Article
- Production of mutant streptavidin protein and investigation of its effect on the performance of streptavidin.Iranian journal of basic medical sciences · 2023Article
- CRISPR-Cas9 Mediated Knockout ofMicroorganisms · 2022Article
- Production of Recombinant Streptavidin and Optimization of Refolding Conditions for Recovery of Biological Activity.Reports of biochemistry & molecular biology · 2018Article
- Antigenic and immunogenic evaluation ofIranian journal of basic medical sciences · 2017Article
- Heterologous expression of a truncated form of human recombinant vascular endothelial growth factor-A and its biological activity in wound healing.Iranian journal of basic medical sciences · 2017Article
- Production of Recombinant Antimicrobial Polymeric Protein Beta Casein-E 50-52 and Its Antimicrobial Synergistic Effects Assessment with Thymol.Molecules (Basel, Switzerland) · 2017Article
- Evolution of the Immune Response against Recombinant Proteins (TcpA, TcpB, and FlaA) as a Candidate Subunit Cholera Vaccine.Journal of immunology research · 2017Article
- Production of recombinant streptokinase from Streptococcus pyogenes isolate and its potential for thrombolytic therapy.Saudi medical journal · 2014Article
- Cloning and expression of the enzymatic region of Streptococcal hyaluronidase.Iranian journal of basic medical sciences · 2014Article
- Recombinant toxin-coregulated pilus A (TcpA) as a candidate subunit cholera vaccine.Iranian journal of microbiology · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
OBJECTIVE(S): Streptokinase (SKa) is an antigenic protein which is secreted by Streptococcus pyogenes. Streptokinase induces inflammation by complement activation, which may play a role in post infectious diseases. In the present study, recombinant streptokinase from S. pyogenes was produced and showed that recombinant SKa protein was recognized by infected human sera using Western blot analysis. MATERIALS AND
methodsIn this study, the ska gene from S. pyogenes was amplified and cloned into pET32a which is a prokaryotic expression vector. pET32a-ska was transformed to Escherichia coli BL21 (DE3) pLysS and gene expression was induced by IPTG. Protein production was improved by modification of composition of the bacterial culture media and altering the induction time by IPTG. The expressed protein was purified by affinity chromatography using the Ni-NTA resin. The integrity of the product was confirmed by Westernblot analysis using infected mice. Serum reactivity of five infected individuals was further analyzed against the recombinant SKa protein.
resultsData indicated that recombinant SKa protein from S. pyogenes can be recognized by patient and mice sera. The concentration of the purified recombinant protein was 3.2 mg/L of initial culture. The highest amount of the expressed protein after addition of IPTG was obtained in a bacterial culture without glucose with the culture optical density of 0.8 (OD600 = 0.8). Conclusion : Present data shows, recombinant SKa protein has same epitopes with natural form of this antigen. Recombinant SKa also seemed to be a promising antigen for the serologic diagnosis of S. pyogenes infections.
Indexed as
Identifiers
24171077PMC3804847W2097962350What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.